Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Death, Sudden, Cardiac

fluorodeoxyglucose f18 has been researched along with Death, Sudden, Cardiac in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Appelbaum, J; Bhan, A; Bogun, FM; Chicos, AB; Crawford, TC; Dickfeld, T; Eagle, KA; Ellenbogen, KA; Froehlich, J; Hoogendoorn, JC; Kapa, S; Kim, HM; Kron, J; Mankad, P; Marchlinski, FE; Murgatroyd, F; Muser, D; Narasimhan, C; Patton, KK; Robinson, MR; Rosenthal, DG; Roukoz, H; Sacher, F; Santangeli, P; Sauer, WH; Siontis, KC; Soejima, K; Vedantham, V; Zeppenfeld, K; Zipse, MM1
Fujii, S; Fukuda, M; Ishiguchi, H; Kawano, R; Kobayashi, S; Nakashima, Y; Nanno, T; Okamura, T; Suga, K; Yano, M; Yano, Y; Yoshiga, Y; Yoshitomi, R1
Birnie, D; Kron, J; Mankad, P; Mitchell, B1
Li, W; Li, X; Mi, H; Tian, Y; Zhang, X; Zhao, M; Zhu, Z1
Berger, RD; Calkins, H; Chrispin, J; Derakhshan, A; Gilotra, NA; Gowani, Z; Habibi, M; Misra, S; Okada, DR; Smith, J; Tandri, H; Zimmerman, SL1
Barnes, A; Booth, HL; Elliott, PM; Garrett, E; Groves, AM; Menezes, LJ; Mohiddin, SA; Patel, RS; Pavlou, M; Porter, JC; Sekhri, N; Wicks, EC1
Birnie, DH; Kandolin, R; Kupari, M; Nery, PB1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Death, Sudden, Cardiac

ArticleYear
Cardiac Sarcoidosis.
    Current cardiology reports, 2019, 11-25, Volume: 21, Issue:12

    Topics: Canada; Cardiomyopathies; Contrast Media; Death, Sudden, Cardiac; Defibrillators, Implantable; Fluorodeoxyglucose F18; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Sarcoidosis; Treatment Outcome

2019

Other Studies

6 other study(ies) available for fluorodeoxyglucose f18 and Death, Sudden, Cardiac

ArticleYear
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
    JAMA cardiology, 2022, 02-01, Volume: 7, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Inflammation; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome

2022
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Heart (British Cardiac Society), 2022, Volume: 108, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Cardiomyopathies; Death, Sudden, Cardiac; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Myocarditis; Oxidative Stress; Prospective Studies; Risk Factors; Sarcoidosis; Tachycardia, Ventricular

2022
Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.
    The international journal of cardiovascular imaging, 2020, Volume: 36, Issue:10

    Topics: Aged; Cardiomyopathies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left

2020
Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    The American journal of cardiology, 2020, 11-01, Volume: 134

    Topics: Adult; Aged; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Ventricular Fibrillation

2020
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    European heart journal. Cardiovascular Imaging, 2018, 07-01, Volume: 19, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiomyopathies; Cause of Death; Cohort Studies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Survival Analysis; Young Adult

2018
Cardiac manifestations of sarcoidosis: diagnosis and management.
    European heart journal, 2017, Sep-14, Volume: 38, Issue:35

    Topics: Adolescent; Adult; Aged; Biomarkers; Biopsy; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Early Diagnosis; Echocardiography; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Young Adult

2017